A Phase IIb Randomised, Double-blind, Placebo-controlled, Multi-centre, Dose-ranging Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Due to Left Heart Disease (WHO Group 2)
Knowledge translation is the art and science of moving evidence into health care policy and practice. Vancouver Coastal Health Research Institute (VCHRI) is proud to support health care professionals to effectively implement evidence-based practice changes to improve patient care. The Knowledge Translation (KT) Challenge, a program run in collaboration with BC Cancer and Providence Health Care, is grounded in capacity building and facilitates health care providers to work with experienced investigators to share knowledge and build connections.
The Canadian Institutes of Health Research (CIHR) has announced the results of its Spring 2024 project grant competition. Congratulations to all the VCHRI researchers who were awarded project grants.
A comprehensive injury prevention initiative developed by Vancouver Coastal Health Research Institute researcher Dr. Babak Shadgan is revolutionizing safety in competitions of Olympic styles of wrestling.
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 24 Weeks in Participants With Eosinophilic Asthma (EXHALE-4)
Vancouver Coastal Health Research Institute (VCHRI) is proud to support future research leaders with the Top Graduating Doctoral Student Awards and the Rising Star Awards. These awards recognize the outstanding efforts of VCHRI trainees whose pursuit of research has made them exceptional role models and significant contributors to the Vancouver Coastal Health and University of British Columbia research community.
The 2024 Top Graduating Doctoral Student Award recipients are:
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 52 Weeks in Participants With Severe Eosinophilic Asthma